Wen PY, Cloughesy TF, Olivero AG, Morrissey KM, et al. First-in-human Phase I study to evaluate the brain-penetrant PI3K/mTOR inhibitor GDC-0084 in patients with progressive or recurrent high-grade glioma. Clin Cancer Res 2020 Jan 14. pii: 1078-0432.CCR-19-2808.
PMID: 31937616